Microdeletions Including FMR1 in Three Female Patients with Intellectual Disability - Further Delineation of the Phenotype and Expression Studies

Fragile X syndrome (FXS) is one of the most common causes of intellectual disability/developmental delay (ID/DD), especially in males. It is caused most often by CGG trinucleotide repeat expansions, and less frequently by point mutations and partial or full deletions of the FMR1 gene. The wide clini...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular syndromology 2014-02, Vol.5 (2), p.65-75
Hauptverfasser: Zink, A.M., Wohlleber, E., Engels, H., Rødningen, O.K., Ravn, K., Heilmann, S., Rehnitz, J., Katzorke, N., Kraus, C., Blichfeldt, S., Hoffmann, P., Reutter, H., Brockschmidt, F.F., Kreiß-Nachtsheim, M., Vogt, P.H., Prescott, T.E., Tümer, Z., Lee, J.A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 75
container_issue 2
container_start_page 65
container_title Molecular syndromology
container_volume 5
creator Zink, A.M.
Wohlleber, E.
Engels, H.
Rødningen, O.K.
Ravn, K.
Heilmann, S.
Rehnitz, J.
Katzorke, N.
Kraus, C.
Blichfeldt, S.
Hoffmann, P.
Reutter, H.
Brockschmidt, F.F.
Kreiß-Nachtsheim, M.
Vogt, P.H.
Prescott, T.E.
Tümer, Z.
Lee, J.A.
description Fragile X syndrome (FXS) is one of the most common causes of intellectual disability/developmental delay (ID/DD), especially in males. It is caused most often by CGG trinucleotide repeat expansions, and less frequently by point mutations and partial or full deletions of the FMR1 gene. The wide clinical spectrum of affected females partly depends on their X-inactivation status. Only few female ID/DD patients with microdeletions including FMR1 have been reported. We describe 3 female patients with 3.5-, 4.2- and 9.2-Mb de novo microdeletions in Xq27.3-q28 containing FMR1. X-inactivation was random in all patients, yet they presented with ID/DD as well as speech delay, macrocephaly and other features attributable to FXS. No signs of autism were present. Here, we further delineate the clinical spectrum of female patients with microdeletions. FMR1 expression studies gave no evidence for an absolute threshold below which signs of FXS present. Since FMR1 expression is known to be highly variable between unrelated females, and since FMR1 mRNA levels have been suggested to be more similar among family members, we further explored the possibility of an intrafamilial effect. Interestingly, FMR1 mRNA levels in all 3 patients were significantly lower than in their respective mothers, which was shown to be specific for patients with microdeletions containing FMR1.
doi_str_mv 10.1159/000357962
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1514432394</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3277852311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c485t-54f73cb4a39b6238880ba15088189ae9336b555be76f5c54cf76d3e2d9d966993</originalsourceid><addsrcrecordid>eNqNkktv1DAUhSMEolXpgj1CltjAImDH8WuDVLUdqNQRFS0LVpGT3My4eJxgO7TzM_jHOJohPMSClS3fT-fce32y7CnBrwlh6g3GmDKhePEgOySck1wKIR7Od64OsuMQbvHEqUIS8jg7KEpBmGT0MPu-NI3vW7AQTe8CunCNHVvjVmix_EiQcehm7QHQAjbaArrS0YCLAd2ZuE5wBGuhiaO26MwEXRtr4hblaDH6uAaPzsAaB3rSRn2H0hu6WoPr43YApF2Lzu8HDyFM9euYjCE8yR512gY43p9H2afF-c3p-_zyw7uL05PLvCklizkrO0GbutRU1bygUkpca8KwlEQqDYpSXjPGahC8Yw0rm07wlkLRqlZxrhQ9yt7udIex3kDbpLG8ttXgzUb7bdVrU_1ZcWZdrfpvFVVCUCKSwMu9gO-_jhBitTGhSQvRDvoxVISRsqQFVeX_oAUtGCtwQl_8hd72o3dpExMlMKW4lIl6taPS54XgoZv7JriaYlHNsUjs898HncmfIfhl-UX7FfgZWF5_3klUQ9sl6tk_qb3LD8tXx-k</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1517033048</pqid></control><display><type>article</type><title>Microdeletions Including FMR1 in Three Female Patients with Intellectual Disability - Further Delineation of the Phenotype and Expression Studies</title><source>Karger Journals Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Zink, A.M. ; Wohlleber, E. ; Engels, H. ; Rødningen, O.K. ; Ravn, K. ; Heilmann, S. ; Rehnitz, J. ; Katzorke, N. ; Kraus, C. ; Blichfeldt, S. ; Hoffmann, P. ; Reutter, H. ; Brockschmidt, F.F. ; Kreiß-Nachtsheim, M. ; Vogt, P.H. ; Prescott, T.E. ; Tümer, Z. ; Lee, J.A.</creator><creatorcontrib>Zink, A.M. ; Wohlleber, E. ; Engels, H. ; Rødningen, O.K. ; Ravn, K. ; Heilmann, S. ; Rehnitz, J. ; Katzorke, N. ; Kraus, C. ; Blichfeldt, S. ; Hoffmann, P. ; Reutter, H. ; Brockschmidt, F.F. ; Kreiß-Nachtsheim, M. ; Vogt, P.H. ; Prescott, T.E. ; Tümer, Z. ; Lee, J.A.</creatorcontrib><description>Fragile X syndrome (FXS) is one of the most common causes of intellectual disability/developmental delay (ID/DD), especially in males. It is caused most often by CGG trinucleotide repeat expansions, and less frequently by point mutations and partial or full deletions of the FMR1 gene. The wide clinical spectrum of affected females partly depends on their X-inactivation status. Only few female ID/DD patients with microdeletions including FMR1 have been reported. We describe 3 female patients with 3.5-, 4.2- and 9.2-Mb de novo microdeletions in Xq27.3-q28 containing FMR1. X-inactivation was random in all patients, yet they presented with ID/DD as well as speech delay, macrocephaly and other features attributable to FXS. No signs of autism were present. Here, we further delineate the clinical spectrum of female patients with microdeletions. FMR1 expression studies gave no evidence for an absolute threshold below which signs of FXS present. Since FMR1 expression is known to be highly variable between unrelated females, and since FMR1 mRNA levels have been suggested to be more similar among family members, we further explored the possibility of an intrafamilial effect. Interestingly, FMR1 mRNA levels in all 3 patients were significantly lower than in their respective mothers, which was shown to be specific for patients with microdeletions containing FMR1.</description><identifier>ISSN: 1661-8769</identifier><identifier>EISSN: 1661-8777</identifier><identifier>DOI: 10.1159/000357962</identifier><identifier>PMID: 24715853</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Original ; Original Article</subject><ispartof>Molecular syndromology, 2014-02, Vol.5 (2), p.65-75</ispartof><rights>2014 S. Karger AG, Basel</rights><rights>Copyright (c) 2014 S. Karger AG, Basel</rights><rights>Copyright © 2014 by S. Karger AG, Basel 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c485t-54f73cb4a39b6238880ba15088189ae9336b555be76f5c54cf76d3e2d9d966993</citedby><cites>FETCH-LOGICAL-c485t-54f73cb4a39b6238880ba15088189ae9336b555be76f5c54cf76d3e2d9d966993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977317/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977317/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,2429,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24715853$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zink, A.M.</creatorcontrib><creatorcontrib>Wohlleber, E.</creatorcontrib><creatorcontrib>Engels, H.</creatorcontrib><creatorcontrib>Rødningen, O.K.</creatorcontrib><creatorcontrib>Ravn, K.</creatorcontrib><creatorcontrib>Heilmann, S.</creatorcontrib><creatorcontrib>Rehnitz, J.</creatorcontrib><creatorcontrib>Katzorke, N.</creatorcontrib><creatorcontrib>Kraus, C.</creatorcontrib><creatorcontrib>Blichfeldt, S.</creatorcontrib><creatorcontrib>Hoffmann, P.</creatorcontrib><creatorcontrib>Reutter, H.</creatorcontrib><creatorcontrib>Brockschmidt, F.F.</creatorcontrib><creatorcontrib>Kreiß-Nachtsheim, M.</creatorcontrib><creatorcontrib>Vogt, P.H.</creatorcontrib><creatorcontrib>Prescott, T.E.</creatorcontrib><creatorcontrib>Tümer, Z.</creatorcontrib><creatorcontrib>Lee, J.A.</creatorcontrib><title>Microdeletions Including FMR1 in Three Female Patients with Intellectual Disability - Further Delineation of the Phenotype and Expression Studies</title><title>Molecular syndromology</title><addtitle>Mol Syndromol</addtitle><description>Fragile X syndrome (FXS) is one of the most common causes of intellectual disability/developmental delay (ID/DD), especially in males. It is caused most often by CGG trinucleotide repeat expansions, and less frequently by point mutations and partial or full deletions of the FMR1 gene. The wide clinical spectrum of affected females partly depends on their X-inactivation status. Only few female ID/DD patients with microdeletions including FMR1 have been reported. We describe 3 female patients with 3.5-, 4.2- and 9.2-Mb de novo microdeletions in Xq27.3-q28 containing FMR1. X-inactivation was random in all patients, yet they presented with ID/DD as well as speech delay, macrocephaly and other features attributable to FXS. No signs of autism were present. Here, we further delineate the clinical spectrum of female patients with microdeletions. FMR1 expression studies gave no evidence for an absolute threshold below which signs of FXS present. Since FMR1 expression is known to be highly variable between unrelated females, and since FMR1 mRNA levels have been suggested to be more similar among family members, we further explored the possibility of an intrafamilial effect. Interestingly, FMR1 mRNA levels in all 3 patients were significantly lower than in their respective mothers, which was shown to be specific for patients with microdeletions containing FMR1.</description><subject>Original</subject><subject>Original Article</subject><issn>1661-8769</issn><issn>1661-8777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkktv1DAUhSMEolXpgj1CltjAImDH8WuDVLUdqNQRFS0LVpGT3My4eJxgO7TzM_jHOJohPMSClS3fT-fce32y7CnBrwlh6g3GmDKhePEgOySck1wKIR7Od64OsuMQbvHEqUIS8jg7KEpBmGT0MPu-NI3vW7AQTe8CunCNHVvjVmix_EiQcehm7QHQAjbaArrS0YCLAd2ZuE5wBGuhiaO26MwEXRtr4hblaDH6uAaPzsAaB3rSRn2H0hu6WoPr43YApF2Lzu8HDyFM9euYjCE8yR512gY43p9H2afF-c3p-_zyw7uL05PLvCklizkrO0GbutRU1bygUkpca8KwlEQqDYpSXjPGahC8Yw0rm07wlkLRqlZxrhQ9yt7udIex3kDbpLG8ttXgzUb7bdVrU_1ZcWZdrfpvFVVCUCKSwMu9gO-_jhBitTGhSQvRDvoxVISRsqQFVeX_oAUtGCtwQl_8hd72o3dpExMlMKW4lIl6taPS54XgoZv7JriaYlHNsUjs898HncmfIfhl-UX7FfgZWF5_3klUQ9sl6tk_qb3LD8tXx-k</recordid><startdate>201402</startdate><enddate>201402</enddate><creator>Zink, A.M.</creator><creator>Wohlleber, E.</creator><creator>Engels, H.</creator><creator>Rødningen, O.K.</creator><creator>Ravn, K.</creator><creator>Heilmann, S.</creator><creator>Rehnitz, J.</creator><creator>Katzorke, N.</creator><creator>Kraus, C.</creator><creator>Blichfeldt, S.</creator><creator>Hoffmann, P.</creator><creator>Reutter, H.</creator><creator>Brockschmidt, F.F.</creator><creator>Kreiß-Nachtsheim, M.</creator><creator>Vogt, P.H.</creator><creator>Prescott, T.E.</creator><creator>Tümer, Z.</creator><creator>Lee, J.A.</creator><general>S. Karger AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201402</creationdate><title>Microdeletions Including FMR1 in Three Female Patients with Intellectual Disability - Further Delineation of the Phenotype and Expression Studies</title><author>Zink, A.M. ; Wohlleber, E. ; Engels, H. ; Rødningen, O.K. ; Ravn, K. ; Heilmann, S. ; Rehnitz, J. ; Katzorke, N. ; Kraus, C. ; Blichfeldt, S. ; Hoffmann, P. ; Reutter, H. ; Brockschmidt, F.F. ; Kreiß-Nachtsheim, M. ; Vogt, P.H. ; Prescott, T.E. ; Tümer, Z. ; Lee, J.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c485t-54f73cb4a39b6238880ba15088189ae9336b555be76f5c54cf76d3e2d9d966993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Original</topic><topic>Original Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zink, A.M.</creatorcontrib><creatorcontrib>Wohlleber, E.</creatorcontrib><creatorcontrib>Engels, H.</creatorcontrib><creatorcontrib>Rødningen, O.K.</creatorcontrib><creatorcontrib>Ravn, K.</creatorcontrib><creatorcontrib>Heilmann, S.</creatorcontrib><creatorcontrib>Rehnitz, J.</creatorcontrib><creatorcontrib>Katzorke, N.</creatorcontrib><creatorcontrib>Kraus, C.</creatorcontrib><creatorcontrib>Blichfeldt, S.</creatorcontrib><creatorcontrib>Hoffmann, P.</creatorcontrib><creatorcontrib>Reutter, H.</creatorcontrib><creatorcontrib>Brockschmidt, F.F.</creatorcontrib><creatorcontrib>Kreiß-Nachtsheim, M.</creatorcontrib><creatorcontrib>Vogt, P.H.</creatorcontrib><creatorcontrib>Prescott, T.E.</creatorcontrib><creatorcontrib>Tümer, Z.</creatorcontrib><creatorcontrib>Lee, J.A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular syndromology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zink, A.M.</au><au>Wohlleber, E.</au><au>Engels, H.</au><au>Rødningen, O.K.</au><au>Ravn, K.</au><au>Heilmann, S.</au><au>Rehnitz, J.</au><au>Katzorke, N.</au><au>Kraus, C.</au><au>Blichfeldt, S.</au><au>Hoffmann, P.</au><au>Reutter, H.</au><au>Brockschmidt, F.F.</au><au>Kreiß-Nachtsheim, M.</au><au>Vogt, P.H.</au><au>Prescott, T.E.</au><au>Tümer, Z.</au><au>Lee, J.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Microdeletions Including FMR1 in Three Female Patients with Intellectual Disability - Further Delineation of the Phenotype and Expression Studies</atitle><jtitle>Molecular syndromology</jtitle><addtitle>Mol Syndromol</addtitle><date>2014-02</date><risdate>2014</risdate><volume>5</volume><issue>2</issue><spage>65</spage><epage>75</epage><pages>65-75</pages><issn>1661-8769</issn><eissn>1661-8777</eissn><abstract>Fragile X syndrome (FXS) is one of the most common causes of intellectual disability/developmental delay (ID/DD), especially in males. It is caused most often by CGG trinucleotide repeat expansions, and less frequently by point mutations and partial or full deletions of the FMR1 gene. The wide clinical spectrum of affected females partly depends on their X-inactivation status. Only few female ID/DD patients with microdeletions including FMR1 have been reported. We describe 3 female patients with 3.5-, 4.2- and 9.2-Mb de novo microdeletions in Xq27.3-q28 containing FMR1. X-inactivation was random in all patients, yet they presented with ID/DD as well as speech delay, macrocephaly and other features attributable to FXS. No signs of autism were present. Here, we further delineate the clinical spectrum of female patients with microdeletions. FMR1 expression studies gave no evidence for an absolute threshold below which signs of FXS present. Since FMR1 expression is known to be highly variable between unrelated females, and since FMR1 mRNA levels have been suggested to be more similar among family members, we further explored the possibility of an intrafamilial effect. Interestingly, FMR1 mRNA levels in all 3 patients were significantly lower than in their respective mothers, which was shown to be specific for patients with microdeletions containing FMR1.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>24715853</pmid><doi>10.1159/000357962</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1661-8769
ispartof Molecular syndromology, 2014-02, Vol.5 (2), p.65-75
issn 1661-8769
1661-8777
language eng
recordid cdi_proquest_miscellaneous_1514432394
source Karger Journals Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Original
Original Article
title Microdeletions Including FMR1 in Three Female Patients with Intellectual Disability - Further Delineation of the Phenotype and Expression Studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A29%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Microdeletions%20Including%20FMR1%20in%20Three%20Female%20Patients%20with%20Intellectual%20Disability%20-%20Further%20Delineation%20of%20the%20Phenotype%20and%20Expression%20Studies&rft.jtitle=Molecular%20syndromology&rft.au=Zink,%20A.M.&rft.date=2014-02&rft.volume=5&rft.issue=2&rft.spage=65&rft.epage=75&rft.pages=65-75&rft.issn=1661-8769&rft.eissn=1661-8777&rft_id=info:doi/10.1159/000357962&rft_dat=%3Cproquest_cross%3E3277852311%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1517033048&rft_id=info:pmid/24715853&rfr_iscdi=true